New Studies: Alivecor ’s Kardiaband Coupled With Apple Watch Detects AFib, Potassium Levels Accurately

ECG wearable manufacturing Alivecor’s Kardiaband was able to detect atrial fibrillation with very high sensitivity according to the latest study of the Cleveland Clinic published early March. When a physician actually helped examine the data, sensitivity reached 99 percent. A second study, conducted by the Mayo Clinic, showed that the ECG device, when paired with new artificial intelligence technology, is able to detect high potassium levels in blood non-invasively, which could signal diabetes or heart failure. Doctor and digital health tech: the best combination AliveCor’s KardiaBand is a novel technology that enables patients to record a rhythm strip using an Apple smartwatch. It is basically a sensor able to detect abnormal heart rhythm and atrial fibrillation (AFib); which sends all its findings to the accompanying app on the Apple Watch. Moreover, Kardiaband’s smart algorithm is able to analyze and predict heart rate. Cleveland Clinic’s study in the Journal of the American College of Cardiology analyzed 169 simultaneous ECG and KardiaBand recordings. They found that compared to ECG recordings, AliveCor’s device interpreted AFib with 93 percent sensitivity and 84 percent specificity. When an actual physician was involved in the interpretation process of 57 non-interpretable recordings, the sensitivity of AFib-detection jumped to 99 percent. Source: The Sceptical Cardiologist Detecting hyperkalemia without blood tests In the second study conducted by the Mayo Cl...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Future of Medicine Health Sensors & Trackers digital digital health ecg Healthcare Innovation technology wearables Source Type: blogs